Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Edap Tms SA EDAP

Healthcare Medical Devices
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public... see more

Recent & Breaking News (NDAQ:EDAP)

EDAP TMS SA to Announce Third Quarter 2021 Financial Results on Wednesday, November 17, 2021

GlobeNewswire November 10, 2021

EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU Program

GlobeNewswire September 28, 2021

EDAP Announces Presentation of Multiple Abstracts Favorably Comparing HIFU to Surgery at the American Urological Association 2021 Annual Meeting

GlobeNewswire September 14, 2021

EDAP to Participate at Upcoming Investor Conferences

GlobeNewswire September 7, 2021

EDAP Reports Second Quarter 2021 Results and Provides Operational Update

GlobeNewswire August 25, 2021

EDAP Announces Select Preliminary Unaudited Second Quarter 2021 Results

GlobeNewswire August 4, 2021

EDAP Issues Letter to Shareholders

GlobeNewswire July 20, 2021

EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company's U.S. Subsidiary

GlobeNewswire June 15, 2021

EDAP Reports First Quarter 2021 Results and Provides Operational Update

GlobeNewswire May 11, 2021

EDAP Announces Pricing of Follow-On Offering

GlobeNewswire April 23, 2021

EDAP Announces Launch of Follow-On Offering

GlobeNewswire April 22, 2021

EDAP Reports Fourth Quarter 2020 Results and Provides Operational Update

GlobeNewswire March 30, 2021

EDAP TMS SA to Announce Fourth Quarter and Full Year 2020 Financial Results on March 30, 2021

GlobeNewswire March 23, 2021

EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US   

GlobeNewswire March 3, 2021

EDAP Announces Record Preliminary Unaudited Fourth Quarter 2020 Revenue of EUR 15.3 Million [$18.3 million], an Increase of 28% Year-Over-Year

GlobeNewswire January 20, 2021

EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference

GlobeNewswire January 19, 2021

EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study comparing HIFU to Radical Prostate Surgery

GlobeNewswire January 14, 2021

EDAP Issues Letter to Shareholders

GlobeNewswire January 6, 2021

EDAP to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

GlobeNewswire January 5, 2021

EDAP Announces End of the Year Focal One® Sales

GlobeNewswire December 30, 2020